Criteria for Verification and Replanning Based on the Adaptive Radiotherapy Protocol "Best for Adaptive Radiotherapy" in Head and Neck Cancer

被引:3
作者
Bak, Bartosz [1 ,2 ]
Skrobala, Agnieszka [1 ,3 ]
Adamska, Anna [4 ]
Kazmierska, Joanna [1 ,2 ]
Jozefacka, Natalia [5 ]
Piotrowski, Tomasz [1 ,3 ]
Malicki, Julian [1 ,3 ]
机构
[1] Poznan Univ Med Sci, Dept Electroradiol, PL-61866 Poznan, Poland
[2] Greater Poland Canc Ctr, Dept Radiotherapy 2, PL-61866 Poznan, Poland
[3] Greater Poland Canc Ctr, Dept Med Phys, PL-61866 Poznan, Poland
[4] Greater Poland Canc Ctr, Dept & Radiotherapy Ward 1, PL-61866 Poznan, Poland
[5] Pedag Univ Krakow, Inst Psychol, PL-30084 Krakow, Poland
来源
LIFE-BASEL | 2022年 / 12卷 / 05期
关键词
radiotherapy planning; replanning; adaptive radiotherapy; head and neck cancer; image-guided radiation therapy; helical tomotherapy; INTENSITY-MODULATED RADIOTHERAPY; RADIATION-THERAPY; PAROTID-GLANDS; WEIGHT-LOSS; HELICAL TOMOTHERAPY; CLINICAL-OUTCOMES; ANATOMIC CHANGES; IMRT; ROBUSTNESS; REDUCTION;
D O I
10.3390/life12050722
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
No clear criteria have yet been established to guide decision-making for patient selection and the optimal timing of adaptive radiotherapy (ART) based on image-guided radiotherapy (IGRT). We have developed a novel protocol-the Best for Adaptive Radiotherapy (B-ART) protocol-to guide patient selection for ART. The aim of the present study is to describe this protocol, to evaluate its validity in patients with head and neck (HN) cancer, and to identify the anatomical and clinical predictors of the need for replanning. We retrospectively evaluated 82 patients with HN cancer who underwent helical tomotherapy (HT) and subsequently required replanning due to soft tissue changes upon daily MVCT. Under the proposed criteria, patients with anatomical changes >3 mm on three to four consecutive scans are candidates for ART. We compared the volumes on the initial CT scan (iCT) and the replanning CT (rCT) scan for the clinical target volumes (CTV1, referring to primary tumor or tumor bed and CTV2, metastatic lymph nodes) and for the parotid glands (PG) and body contour (B-body). The patients were stratified by primary tumor localization, clinical stage, and treatment scheme. The main reasons for replanning were: (1) a planning target volume (PTV) outside the body contour (n = 70; 85.4%), (2) PG shrinkage (n = 69; 84.1%), (3) B-body deviations (n = 69; 84.1%), and (4) setup deviations (n = 40; 48.8%). The replanning decision was made, on average, during the fourth week of treatment (n = 47; 57.3%). The mean reductions in the size of the right and left PG volumes were 6.31 cc (20.9%) and 5.98 cc (20.5%), respectively (p < 0.001). The reduction in PG volume was >= 30% in 30 patients (36.6%). The volume reduction in all of the anatomical structures was statistically significant. Four variables-advanced stage disease (T3-T4), chemoradiation, increased weight loss, and oropharyngeal localization-were significantly associated with the need for ART. The B-ART protocol provides clear criteria to eliminate random errors, and to allow for an early response to relevant changes in target volumes.
引用
收藏
页数:14
相关论文
共 42 条
  • [1] Bak B, 2022, CANCER RADIOTHER, V26, P502, DOI [10.1016/j.canrad.2021.08.019, 10.1016/icanrad.2021,08,019]
  • [2] Bak B., 2014, IN YNIER FIZ MED, V3, P319
  • [3] Adaptive radiotherapy for head and neck cancer reduces the requirement for rescans during treatment due to spinal cord dose
    Belshaw, Louise
    Agnew, Christina E.
    Irvine, Denise M.
    Rooney, Keith P.
    McGarry, Conor K.
    [J]. RADIATION ONCOLOGY, 2019, 14 (01)
  • [4] Patterns of practice for adaptive and real-time radiation therapy (POP-ART RT) part II: Offline and online plan adaption for interfractional changes
    Bertholet, Jenny
    Anastasi, Gail
    Noble, David
    Bel, Arjan
    van Leeuwen, Ruud
    Roggen, Toon
    Duchateau, Michael
    Pilskog, Sara
    Garibaldi, Cristina
    Tilly, Nina
    Garcia-Molla, Rafael
    Bonaque, Jorge
    Oelfke, Uwe
    Aznar, Marianne C.
    Ben Heijmen
    [J]. RADIOTHERAPY AND ONCOLOGY, 2020, 153 : 88 - 96
  • [5] Impact of repeat computerized tomography replans in the radiation therapy of head and neck cancers
    Bhandari, Virendra
    Patel, Prapti
    Gurjar, Om Prakash
    Gupta, Krishna Lal
    [J]. JOURNAL OF MEDICAL PHYSICS, 2014, 39 (03) : 164 - 168
  • [6] CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines
    Brouwer, Charlotte L.
    Steenbakkers, Roel J. H. M.
    Bourhis, Jean
    Budach, Wilfried
    Grau, Cai
    Gregoire, Vincent
    van Herk, Marcel
    Lee, Anne
    Maingon, Philippe
    Nutting, Chris
    O'Sullivan, Brian
    Porceddu, Sandro V.
    Rosenthal, David I.
    Sijtsema, Nanna M.
    Langendijk, Johannes A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2015, 117 (01) : 83 - 90
  • [7] Head and neck adaptive radiotherapy: Predicting the time to replan
    Brown, Elizabeth
    Owen, Rebecca
    Harden, Fiona
    Mengersen, Kerrie
    Oestreich, Kimberley
    Houghton, Whitney
    Poulsen, Michael
    Harris, Selina
    Lin, Charles
    Porceddu, Sandro
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 (04) : 460 - 467
  • [8] Adaptive intensity-modulated radiotherapy in head-and-neck cancer: A volumetric and dosimetric study
    Burela, Nagarjuna
    Soni, Tej Prakash
    Patni, Nidhi
    Natarajan, Thiru
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2019, 15 (03) : 533 - 538
  • [9] Adaptive Radiotherapy Using Helical Tomotherapy for Head and Neck Cancer in Definitive and Postoperative Settings: Initial Results
    Capelle, L.
    Mackenzie, M.
    Field, C.
    Parliament, M.
    Ghosh, S.
    Scrimger, R.
    [J]. CLINICAL ONCOLOGY, 2012, 24 (03) : 208 - 215
  • [10] A Nomogram to predict parotid gland overdose in head and neck IMRT
    Castelli, J.
    Simon, A.
    Rigaud, B.
    Lafond, C.
    Chajon, E.
    Ospina, J. D.
    Haigron, P.
    Laguerre, B.
    Loubiere, A. Ruffier
    Benezery, K.
    de Crevoisier, R.
    [J]. RADIATION ONCOLOGY, 2016, 11